Published in Biol Psychiatry on November 15, 2001
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | NCT00021528
Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend (2006) 2.98
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Experimental design and primary data analysis methods for comparing adaptive interventions. Psychol Methods (2012) 2.01
A clinical risk stratification tool for predicting treatment resistance in major depressive disorder. Biol Psychiatry (2013) 1.90
The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry (2008) 1.86
Customizing treatment to the patient: adaptive treatment strategies. Drug Alcohol Depend (2007) 1.63
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry (2012) 1.48
Continuous evaluation of evolving behavioral intervention technologies. Am J Prev Med (2013) 1.47
Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Stat Med (2012) 1.47
Design elements in implementation research: a structured review of child welfare and child mental health studies. Adm Policy Ment Health (2011) 1.29
Integrating Decision Making and Mental Health Interventions Research: Research Directions. Clin Psychol (New York) (2006) 1.26
Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav (2011) 1.22
What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology (2010) 1.17
Sequential causal inference: application to randomized trials of adaptive treatment strategies. Stat Med (2008) 1.17
Enhancing validity in co-occurring disorders treatment research. Schizophr Bull (2006) 1.06
Preference in random assignment: implications for the interpretation of randomized trials. Adm Policy Ment Health (2009) 0.96
A multiple imputation strategy for sequential multiple assignment randomized trials. Stat Med (2014) 0.95
Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives. Dialogues Clin Neurosci (2011) 0.94
Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. J Clin Psychiatry (2010) 0.88
Unpacking the black box of implementation: the next generation for policy, research and practice. Adm Policy Ment Health (2013) 0.87
Clinical equipoise and personal equipoise: two necessary ingredients for reducing bias in manual therapy trials. J Man Manip Ther (2011) 0.85
Telephone and in-person cognitive behavioral therapy for major depression after traumatic brain injury: a randomized controlled trial. J Neurotrauma (2015) 0.80
Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data. Pharmacoepidemiol Drug Saf (2012) 0.80
Innovative Clinical Trial Designs: Toward a 21st-Century Health Care System. Stat Biosci (2011) 0.79
Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches. Psychiatry Investig (2009) 0.79
Innovative designs of point-of-care comparative effectiveness trials. Contemp Clin Trials (2015) 0.78
Current perspectives in the management of treatment-resistant depression. Dialogues Clin Neurosci (2004) 0.78
Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatr Dis Treat (2005) 0.77
Patient-reported outcomes before and after treatment of major depressive disorder. Dialogues Clin Neurosci (2014) 0.76
Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects. BMC Med Res Methodol (2016) 0.75
The importance of the discourse on the method. Child Adolesc Psychiatry Ment Health (2010) 0.75
Design and inference for the intent-to-treat principle using adaptive treatment. Stat Med (2015) 0.75
Adaptive Interventions in Child and Adolescent Mental Health. J Clin Child Adolesc Psychol (2016) 0.75
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial? J Clin Psychiatry (2012) 0.75
A decision-making framework for adaptive pain management. Health Care Manag Sci (2013) 0.75
The Relations of Cognitive, Behavioral, and Physical Activity Variables to Depression Severity in Traumatic Brain Injury: Reanalysis of Data From a Randomized Controlled Trial. J Head Trauma Rehabil (2017) 0.75
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86
Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA (2001) 5.37
Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv (2001) 4.93
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry (1999) 4.22
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Coming to terms with the terms of risk. Arch Gen Psychiatry (1997) 3.98
The role of psychotherapy in the treatment of depression: review of two practice guidelines. Arch Gen Psychiatry (1996) 3.95
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry (1997) 3.71
Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index (PSQI) Sleep (1991) 3.43
Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Arch Gen Psychiatry (1988) 3.32
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol (1996) 3.28
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry (1998) 3.27
Flexible treatment strategies in chronic disease: clinical and research implications. Biol Psychiatry (2000) 3.21
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry (1997) 3.15
The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). Psychophysiology (2001) 3.15
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA (1994) 2.74
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry (2001) 2.70
The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatr Serv (1999) 2.68
Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry (1990) 2.66
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med (1997) 2.62
Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry (2000) 2.52
Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol (2001) 2.49
PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry (1999) 2.48
Redefining the role of psychiatry in medicine. Am J Psychiatry (1996) 2.45
Psychomotor symptoms of depression. Am J Psychiatry (1997) 2.45
Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab (1996) 2.44
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. Am J Psychiatry (1990) 2.35
When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry (1997) 2.35
Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry (1996) 2.32
Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord (1997) 2.30
Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry (2000) 2.30
Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA (1998) 2.27
Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry (1995) 2.23
Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry (1998) 2.23
Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry (1999) 2.23
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 2.21
Memory and ECT: from polarization to reconciliation. J ECT (2000) 2.18
Electro-convulsive therapy practices in the community. Psychol Med (2001) 2.15
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand (2013) 2.14
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry (1998) 2.12
Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry (1994) 2.12
Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry (1997) 2.10
Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry (2000) 2.06
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol (1998) 2.01
Screening for anxiety and depression in early adolescence. J Am Acad Child Adolesc Psychiatry (2001) 2.00
Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry (2001) 1.93
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry (2000) 1.91
Competence of depressed patients for consent to research. Am J Psychiatry (1999) 1.91
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med (2009) 1.91
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Sleep-wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA (1982) 1.90
Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J ECT (2000) 1.89
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ (2001) 1.87
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry (1999) 1.85
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychol Med (2011) 1.83
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med (2000) 1.82
Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry (2001) 1.80
Does ECT alter brain structure? Am J Psychiatry (1994) 1.78
Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry (2001) 1.74
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry (1995) 1.73
Sleep stage physiology, mood, and vigilance responses to total sleep deprivation in healthy 80-year-olds and 20-year-olds. Psychophysiology (1990) 1.71
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med (2010) 1.71
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Am J Psychiatry (1997) 1.70
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Autonomic reactivity and psychopathology in middle childhood. Br J Psychiatry (2001) 1.68
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand (2009) 1.67